Ensuring Safety & Compliance in Extractables & Leachables in Cell & Gene Therapy
Time: 11:15 am
day: Conference Day One
Details:
- Evaluate materials and components used across our cell and gene therapy workflows for potential E&L risks
- How we designed and implemented a tailored E&L study to fit our specific product format and manufacturing process
- Interpreting results to guide material selection, improve product safety, and support successful development milestones
